Skip to main content

Hormone Replacement Therapy: Shortages

Question for Department of Health and Social Care

UIN 104415, tabled on 6 December 2022

To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of reports that women are struggling to access HRT despite medical bodies reporting no supply issues.

Answered on

12 December 2022

There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, a range of factors including an increase in demand has led to issues with a limited number of products. We have been working with suppliers, stakeholders and the National Health Service and the Medicines and Healthcare products Regulatory Agency to maintain overall supply, including expediting resupply dates of the disrupted HRT products.

Since Serious Shortage Protocols (SSPs) on specific HRT products were introduced to ensure even distribution and allow alternative products to be dispensed, supplies have now improved and recently, several SSPs have been removed. Suppliers have secured additional stock of products experiencing shortages and deliveries have been expedited. We share regular communications on shortages, discontinuations and supply information with the NHS.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.